Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization.

Studies evaluating the risk of methicillin-resistant Staphylococcus aureus (MRSA)-associated sequelae in colonized or infected inpatients have not extended follow-up into the period after discharge from the hospital. We determined the 18-month risk of MRSA infection among 209 adult patients newly identified as harboring MRSA. Twenty-nine percent of patients (60 patients) developed subsequent MRSA infections (90 infections). These infections were often severe. Twenty-eight percent of infections (25 of 90) involved bacteremia, and 56% (50 of 90) involved pneumonia, soft tissue infection, osteomyelitis, or septic arthritis. Eighty percent of patients (48 of 60) with subsequent MRSA infection developed the infection at a new site, and 49% of new MRSA infections (44 of 90) first became manifest after discharge from the hospital. Accurate assessment of the risk of MRSA-associated sequelae requires prolonged follow-up after discharge.

[1]  D. Maki,et al.  A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.

[2]  B. Doebbeling,et al.  Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Swanston Wh Methicillin resistant Staphylococcus aureus. , 1999 .

[4]  J. Boyce Should We Vigorously Try to Contain and Control Methicillin-Resistant Staphylococcus aureus? , 1991, Infection Control & Hospital Epidemiology.

[5]  CDC definitions for nosocomial infections, 1988. , 1989, The American review of respiratory disease.

[6]  A. van Belkum,et al.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks , 1997, Clinical microbiology reviews.

[7]  R. Wenzel,et al.  Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[9]  Adel Ben Ali,et al.  Colonization With Methicillin-Resistant Staphylococcus aureus in ICU Patients Morbidity, Mortality, and Glycopeptide Use , 2001, Infection Control & Hospital Epidemiology.

[10]  Á. Asensio,et al.  Colonization and Infection With Methicillin-Resistant Staphylococcus aureus: Associated Factors and Eradication , 1996, Infection Control & Hospital Epidemiology.

[11]  J. Ariza,et al.  Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[12]  K. Plaisance,et al.  MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. , 2001, The Journal of hospital infection.

[13]  Nnis System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[14]  W J Martone,et al.  National nosocomial infections surveillance system (NNIS): description of surveillance methods. , 1991, American journal of infection control.

[15]  B. de Jonghe,et al.  “Colonization Pressure” and Risk of Acquisition of Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit , 2000, Infection Control & Hospital Epidemiology.

[16]  J. Boyce Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? , 1991 .

[17]  National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001. , 2001, American journal of infection control.

[18]  Y. Asada,et al.  Staphylococcus aureus Isolated from Nostril Anteriors and Subungual Spaces of the Hand: Comparative Study of Medical Staff, Patients, and Normal Controls , 1995, The Journal of dermatology.

[19]  D. Gregson,et al.  Hospital- and Community-Based Surveillance of Methicillin-Resistant Staphylococcus aureus: Previous Hospitalization is the Major Risk Factor , 2000, Infection Control & Hospital Epidemiology.

[20]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[21]  Robert E. Johnson,et al.  From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, JAMA.

[22]  R. Coello,et al.  Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. , 1997, The Journal of hospital infection.

[23]  Claude Carbón Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. , 1999, The Journal of antimicrobial chemotherapy.

[24]  N. Hicks,et al.  Carriage and community treatment of methicillin-resistant Staphylococcus aureus: what happens to colonized patients after discharge? , 1991, The Journal of hospital infection.

[25]  D. Flournoy,et al.  The relationship of immunity and nutrition to the acquisition of methicillin-resistant Staphylococcus aureus. , 1991, Journal of the National Medical Association.